Advances in the clinical management of uveal melanoma

RD Carvajal, JJ Sacco, MJ Jager… - Nature reviews Clinical …, 2023‏ - nature.com
Melanomas arising in the uveal tract of the eye are a rare form of the disease with a biology
and clinical phenotype distinct from their more common cutaneous counterparts. Treatment …

Uveal melanoma: relatively rare but deadly cancer

S Kaliki, CL Shields - Eye, 2017‏ - nature.com
Although it is a relatively rare disease, primarily found in the Caucasian population, uveal
melanoma is the most common primary intraocular tumor in adults with a mean age …

Treatment of uveal melanoma: where are we now?

J Yang, DK Manson, BP Marr… - … advances in medical …, 2018‏ - journals.sagepub.com
Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular
malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop …

[HTML][HTML] Metastatic uveal melanoma: The final frontier

ES Rantala, MM Hernberg, S Piperno-Neumann… - Progress in retinal and …, 2022‏ - Elsevier
Abstract Treatment of primary intraocular uveal melanoma has developed considerably, its
driver genes are largely unraveled, and the ways to assess its risk for metastases are very …

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

BA Krantz, N Dave, KM Komatsubara… - Clinical …, 2017‏ - Taylor & Francis
Uveal melanoma (UM) is the most common intraocular malignancy and arises from
melanocytes in the iris, ciliary body, or choroid. Early diagnosis and local treatment is …

[HTML][HTML] Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) …

L Khoja, EG Atenafu, S Suciu, S Leyvraz, T Sato… - Annals of …, 2019‏ - Elsevier
Background Despite the completion of numerous phase II studies, a standard of care
treatment has yet to be defined for metastatic uveal melanoma (mUM). To determine …

Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis

ES Rantala, M Hernberg, TT Kivelä - Melanoma research, 2019‏ - journals.lww.com
The overall survival (OS) of patients with metastatic uveal melanoma is short, the evidence
for effectiveness of treatments is limited, and no consensus on the choice of treatment exists …

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

RD Carvajal, JA Sosman, JF Quevedo, MM Milhem… - Jama, 2014‏ - jamanetwork.com
Importance Uveal melanoma is characterized by mutations inGNAQandGNA11, resulting in
mitogen-activated protein kinase pathway activation. Objective To assess the efficacy of …

[HTML][HTML] The treatment of advanced melanoma: Current approaches and new challenges

A Boutros, E Croce, M Ferrari, R Gili, G Massaro… - Critical Reviews in …, 2024‏ - Elsevier
In recent years, advances in melanoma treatment have renewed patient hope. This
comprehensive review emphasizes the evolving treatment landscape, particularly …

Uveal melanoma: estimating prognosis

S Kaliki, CL Shields, JA Shields - Indian journal of ophthalmology, 2015‏ - journals.lww.com
Uveal melanoma is the most common primary malignant tumor of the eye in adults,
predominantly found in Caucasians. Local tumor control of uveal melanoma is excellent, yet …